Xuan Zhang | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Assist. Prof. Dr. Xuan Zhang | Medicine and Health Sciences | Best Researcher Award

Hong Kong Baptist University | Hong Kong

Dr. Xuan Zhang is a highly respected Lecturer II at the School of Chinese Medicine, Hong Kong Baptist University. As a registered Chinese Medicine Practitioner in both Mainland China and Hong Kong, she has cultivated a strong academic and clinical foundation rooted in traditional Chinese medicine principles. Since joining HKBU in 2016, she has significantly contributed to teaching, research, and international academic collaborations. Her leadership in evidence-based research, combined with her deep understanding of the Huangdi Neijing and classical theories such as the Five Circuits and Six Qi, positions her as a pioneer in integrating tradition with modern scientific approaches. Dr. Zhang has led or participated in more than 15 externally funded projects and published over 100 peer-reviewed articles, with a strong record of first- and corresponding-author contributions.

Professional Profile

ORCID

Scopus

Education

Dr. Zhang earned her Ph.D. in Chinese Medicine from the prestigious Beijing University of Chinese Medicine. Her doctoral training provided a rich combination of theoretical studies, classical text interpretation, and hands-on clinical applications. The academic environment fostered her early interest in integrating traditional Chinese medical theories with scientific methodologies. Her educational path laid the groundwork for her to pursue rigorous research in both the theoretical foundations and practical applications of Chinese medicine, particularly in the fields of epidemiology, gastrointestinal diseases, and methodological development.

Experience

With close to a decade of academic and clinical teaching experience, Dr. Zhang has taken on numerous roles that extend beyond the classroom. Since joining HKBU in 2016, she has secured seven research grants as Principal Investigator and served as co-investigator in multiple national-level projects funded by organizations such as the National Natural Science Foundation of China and the Chinese Medicine Development Fund (HKSAR). Her expertise has led to contributions in reporting guideline development, multicentre clinical trials, and telemedicine studies. She also serves on editorial boards for international journals such as Scientific Reports, BMC Medical Research Methodology, and the Journal of Traditional Chinese Medical Sciences, underscoring her standing in the academic community.

Research Interests

Dr. Zhang’s core research areas include: (1) theoretical and clinical research based on the Huangdi Neijing, with a focus on the “Five Circuits and Six Qi” (Wu Yun Liu Qi); (2) development of evidence-based Chinese medicine practices and methodological reporting standards; (3) clinical studies on gastrointestinal diseases such as IBS and ulcerative colitis; and (4) epidemiological research in infectious diseases within the framework of Chinese medicine. She has championed multidisciplinary and cross-regional collaborations that explore the integration of data science with ancient medical systems. Her ongoing work also addresses the modernization and standardization of traditional practices to ensure global acceptance and scientific validation.

Awards and Recognition

Dr. Zhang has received numerous awards for her outstanding research and contributions to Chinese medicine. She was named among China’s CNKI Highly Cited Scholars (Top 1%) and received the “Top Cited Article” award in the Journal of Evidence-Based Medicine. She was also honored as one of the “100 Outstanding Reviewers” of the China Journal of Traditional Chinese Medicine and Pharmacy and recognized as the “1st Qiu Zhen Scholars of Chinese Medicine.” Additionally, she earned the “Top Articles in Outstanding S&T Journals of China” award twice and the “Third Prize of Science and Technology Award” from the China Association of Chinese Medicine. These accolades reflect her significant impact on both theoretical and applied Chinese medicine research.

Publications

  1. Title: A Protocol for Developing, Disseminating, and Implementing a Core Outcome Set for Clinical Trials of Integrative Chinese and Western Medicine for Ulcerative Colitis
    Journal: Journal of Integrative Medicine
    Published on: 31 Jul 2025

  2. Title: Butyrate-producing commensal bacteria mediates the efficacy of herbal medicine JCM-16021 on abdominal pain in diarrhea-predominant irritable bowel syndrome: a randomized clinical trial
    Journal: Phytomedicine
    Published on: Sep 2025

  3. Title: Outcomes reporting in clinical trials of Chinese herbal medicine on ulcerative colitis: A systematic review
    Journal: Journal of Evidence-Based Medicine
    Published on: 28 Oct 2024

  4. Title: Suboptimal reporting of randomized controlled trials on non-pharmacological therapies in Chinese medicine
    Journal: Frontiers in Medicine
    Published on: 17 Jun 2024

  5. Title: Transparency and reporting characteristics of randomized controlled trials with Chinese herbal medicine formulas interventions
    Journal: Frontiers of Medicine
    Published on: 17 May 2024

  6. Title: STandards for Reporting Interventions in Clinical Trials Of Tuina/Massage (STRICTOTM): Extending the CONSORT Statement
    Journal: Journal of Evidence-Based Medicine
    Published on: 14 Mar 2023

  7. Title: Reporting assessment of multicenter clinical trial protocols: a cross-sectional study
    Journal: Journal of Evidence-Based Medicine
    Published on: 03 Mar 2023

Conclusion

Dr. Xuan Zhang is a distinguished researcher, educator, and clinical scholar whose work reflects a deep integration of traditional Chinese medicine principles with contemporary clinical and scientific practices. Her extensive publication record, grant leadership, and editorial responsibilities demonstrate her strong research acumen and commitment to globalizing Chinese medicine. With high-impact contributions, international collaborations, and multiple recognitions for academic excellence, Dr. Zhang is a highly deserving candidate for the Best Researcher Award. Her work continues to shape the future of evidence-based Chinese medicine and methodological innovation.

Kyaw Thein | Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Assist. Prof. Dr. Kyaw Thein | Health Sciences | Best Researcher Award

MD | Comprehensive Cancer Centers of Nevada – Central Valley | United States

Dr. Kyaw Zin Thein, MD, is a highly skilled Medical Oncologist and Hematologist currently practicing at the Central Valley Treatment Center – Twain, affiliated with the Comprehensive Cancer Centers of Nevada. He also serves as a Clinical Assistant Professor at Touro University Nevada (TUN) and the University of Nevada, Las Vegas (UNLV). His dedication to patient care, research, and education has solidified his reputation as a leader in precision oncology and hematology.

Profile

Scopus

Google scholar

Orcid

Strengths for the Awards

  • Impressive Academic and Clinical Training
    • Dr. Kyaw Zin Thein has a robust academic background, including advanced fellowships in hematology, oncology, and investigational cancer therapeutics at world-renowned institutions such as MD Anderson Cancer Center.
    • A double board-certified oncologist and hematologist with certifications valid through 2029, showcasing his extensive expertise and commitment to maintaining professional standards.
  • Research Contributions and Publications
    • Author of 53 peer-reviewed journal articles, demonstrating significant contributions to advancing knowledge in oncology and hematology.
    • Published book chapters on cutting-edge topics like poly (ADP-ribose) polymerase inhibitors and multidisciplinary paradigms for head and neck cancer, reflecting his thought leadership in the field.
  • Teaching and Mentorship
    • Active roles as Clinical Assistant Professor at UNLV and Touro University Nevada, contributing to medical education.
    • Mentorship of numerous trainees, ranging from medical students to fellows, highlighting his commitment to shaping the next generation of oncologists and researchers.
  • Leadership and Awards
    • Held leadership roles, including Chief Fellow, Chief Resident, and committee member positions at esteemed institutions.
    • Recipient of multiple awards, such as the ASH Abstract Achievement Award and Research Recognition Awards, underscoring his excellence in research and clinical practice.

Education 🎓

Dr. Thein completed his M.B., B.S. (Doctor of Medicine) at the Institute of Medicine 1, Yangon, Myanmar (2004–2010). His advanced training includes:

  • Residency in Internal Medicine at Kingsbrook Jewish Medical Center, NY (2012–2015).
  • Fellowship in Hematology & Medical Oncology at Texas Tech University Health Sciences Center, TX (2016–2019).
  • Advanced Fellowships in Investigational Cancer Therapeutics and Oncologic Emergency Medicine at the University of Texas MD Anderson Cancer Center (2015–2020).

Professional Experience 💼

Dr. Thein has held numerous prestigious positions:

  • Medical Oncologist/Hematologist, Central Valley Treatment Center, Nevada (2023–present).
  • Assistant Professor of Medicine, Division of Hematology and Medical Oncology, Oregon Health & Science University (OHSU) (2020–2023).
  • Chief Fellow, Texas Tech University Health Sciences Center (2018–2019).
  • Member of multiple professional committees, including the Knight Cancer Institute’s Data and Safety Monitoring Committee.

Research Interests On Health Sciences🔬

Dr. Thein’s research focuses on precision oncology, investigational cancer therapeutics, and immunotherapy. He has contributed extensively to advancing cancer care through his work on targeted therapies, combination regimens, and innovative diagnostic methods.

Awards & Recognitions 🏆

Dr. Thein has received numerous accolades, including:

  • ASH Abstract Achievement Award, American Society of Hematology (2016).
  • Research Recognition Awards from Kingsbrook Jewish Medical Center (2014, 2015).
  • Excellence in Education Award, Myanmar American Medical Education Society (2011).

Publications 📚

  • Copper deficiency anemia
    • Authors: ZW Myint, TH Oo, KZ Thein, AM Tun, H Saeed
    • Year: 2018
    • Citations: 298
  • 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy
    • Authors: G Han, G Yang, D Hao, Y Lu, K Thein, BS Simpson, J Chen, R Sun, et al.
    • Year: 2021
    • Citations: 136
  • Precision therapy for RET-altered cancers with RET inhibitors
    • Authors: KZ Thein, V Velcheti, BHM Mooers, J Wu, V Subbiah
    • Year: 2021
    • Citations: 112
  • Adverse effects of immune checkpoint therapy in cancer patients visiting the emergency department of a comprehensive cancer center
    • Authors: I El Majzoub, A Qdaisat, KZ Thein, MA Win, MM Han, K Jacobson, et al.
    • Year: 2019
    • Citations: 91
  • Acute symptomatic hypocalcemia from immune checkpoint therapy-induced hypoparathyroidism
    • Authors: MA Win, KZ Thein, A Qdaisat, SCJ Yeung
    • Year: 2017
    • Citations: 83
  • The contemporary management of cancers of the sinonasal tract in adults
    • Authors: R Thawani, MS Kim, A Arastu, Z Feng, MT West, NF Taflin, KZ Thein, R Li, et al.
    • Year: 2023
    • Citations: 74
  • Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers
    • Authors: B Garmezy, J Gheeya, HY Lin, Y Huang, T Kim, X Jiang, KZ Thein, et al.
    • Year: 2022
    • Citations: 74
  • Therapeutics targeting mutant KRAS
    • Authors: KZ Thein, AB Biter, DS Hong
    • Year: 2021
    • Citations: 55
  • Pernicious anemia: Pathophysiology and diagnostic difficulties
    • Authors: TW Htut, KZ Thein, TH Oo
    • Year: 2021
    • Citations: 52
  • Venous thromboembolism risk in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with combined CDK 4/6 inhibitors plus endocrine therapy
    • Authors: KZ Thein, TW Htut, S Ball, S Swarup, A Sultan, TH Oo
    • Year: 2020
    • Citations: 45

Conclusion 🌟

Dr. Kyaw Zin Thein is a visionary leader in oncology and hematology, with a career distinguished by cutting-edge research, impactful teaching, and exceptional clinical care. His dedication to advancing cancer therapies and mentoring future medical professionals underscores his commitment to transforming cancer treatment and education worldwide.

Massimo Petruzzi | Health Sciences | Excellence Award (Any Scientific field)

Published on by Forensic Scientist

Prof. Massimo Petruzzi | Health Sciences | Excellence Award (Any Scientific field)

Associate Professor | University of bari | Italy

Prof. Massimo Petruzzi is a distinguished Italian scholar in the field of oral medicine and stomatology. With a career spanning over two decades, he has made significant contributions to academic, clinical, and research domains. Currently serving as an Associate Professor at the University of Bari, his expertise in dentistry, oral pathology, and surgical interventions has earned him national and international recognition. Prof. Petruzzi is also a lecturer at the University of Bern, sharing his knowledge with the global academic community.

Profile

Strenghts for the Awards

  • Educational Achievements:
    • Completed scientific high school education with the highest honors (60/60).
    • Achieved a degree in Dentistry and Prosthetics with 110/110 and laude, accompanied by special commendations from the evaluation committee.
    • Completed a Ph.D. in Orto-Fonato-Rino-Stomatognatodonzia with substantial expertise in dental and oral sciences.
  • Professional Experience and Contributions:
    • Active researcher since 2005, consistently advancing in the academic field to become a full professor.
    • Extensive teaching portfolio spanning undergraduate, postgraduate, and doctoral programs, including mentoring doctoral students in oral pathology and medicine.
    • Engaged in interdisciplinary teaching and research collaborations at prestigious institutions like the University of Bern, Switzerland.
  • Specialization and Recognition:
    • Specialization in Chirurgia Odontostomatologica (Oral and Dental Surgery), securing top grades and recognition.
    • Winner of competitive research grants and academic positions in Italy, demonstrating his excellence in research and academia.
  • Publications and Research Contributions:
    • Prolific academic output with substantial contributions to research in Malattie Odontostomatologiche (Odontostomatological Diseases).
    • Expertise in clinical oral surgery and pathology, with significant impact on advancing dental practices.
  • Interdisciplinary Roles:
    • Served as an expert consultant for the Court of Taranto and military institutions, showcasing his ability to apply his research and expertise beyond academia.
    • Delivered numerous lectures and seminars, promoting oral health education and evidence-based dentistry practices.

Education 🎓

Prof. Petruzzi’s academic journey is marked by excellence. He graduated with a scientific diploma (Maturità Scientifica) in 1993, followed by a degree in Dentistry and Prosthodontics in 1999 from the University of Bari, where he achieved top honors (110/110 cum laude). In 2000, he specialized in Oral Medicine and Pathology and completed his Ph.D. in Orto-Fonato-Rino-Stomatognathodontics in 2004. His rigorous academic foundation was further bolstered by a specialization in Oral Surgery in 2012, where he again achieved top grades.

Experience 🏢

Prof. Petruzzi began his career as a university researcher in 2005 and achieved tenure in 2008. Since 2015, he has held the position of Associate Professor in Oral and Stomatological Diseases at the University of Bari. His teaching responsibilities span undergraduate, postgraduate, and doctoral levels, and he has been actively involved in developing interdisciplinary courses. His military service as a Dental Officer in the Italian Navy from 2000 to 2001 highlights his versatility and commitment to service.

🔬Research Interests  On Health Sciences

Prof. Petruzzi’s research primarily focuses on oral medicine, pathology, and stomatological diseases. He has contributed extensively to the understanding and treatment of oral mucosal diseases, laser dentistry, and minimally invasive surgical techniques. His work is characterized by a strong emphasis on translational research, aiming to bridge the gap between scientific discoveries and clinical applications.

Awards and Recognitions 🏆

Throughout his career, Prof. Petruzzi has received numerous awards, including competitive scholarships for his Ph.D. program and distinctions for academic excellence. His habilitation for the role of Full Professor in Oral Diseases (2017–2028) is a testament to his professional achievements and expertise in the field. Additionally, he has been recognized for his contributions to scientific research and education at both national and international levels.

Final Note 📘

Prof. Massimo Petruzzi exemplifies academic and professional excellence in oral medicine and dentistry. His contributions to research, teaching, and clinical practice have significantly advanced the field, benefiting both students and patients. Prof. Petruzzi continues to inspire the next generation of dental professionals with his dedication to innovation and education.

Publications 📚🖋️

1. Hepatitis C Virus (HCV) Infection: Pathogenesis, Oral Manifestations, and the Role of Direct-Acting Antiviral Therapy: A Narrative Review

  • Authors: Di Stasio, D.; Guida, A.; Romano, A.; Fiori, F.; Lucchese, A.
  • Publication Year: 2024
  • Citations: 1

2. Oral Manifestations in Paraneoplastic Syndromes: A Systematic Review and Meta-Analysis

  • Authors: Messina, S.; De Falco, D.; Petruzzi, M.
  • Publication Year: 2024
  • Citations: 0

3. Proposal of a Modified Technique of Nikolsky’s Sign in Oral Autoimmune Vesiculobullous Diseases

  • Authors: Petruzzi, M.
  • Publication Year: 2024
  • Citations: 0

4. Diagnostic Delay in Autoimmune Oral Diseases

  • Authors: Petruzzi, M.; Della Vella, F.; Squicciarini, N.; Lucchese, A.; van der Waal, I.
  • Publication Year: 2023
  • Citations: 10

5. Blood Clotting Dissolution in the Presence of a Magnetic Field and Preliminary Study with MG63 Osteoblast-like Cells—Further Developments for Guided Bone Regeneration?

  • Authors: Di Gioia, S.; Milillo, L.; Hossain, M. N.; Petruzzi, M.; Conese, M.
  • Publication Year: 2023
  • Citations: 0

6. Exploring the Association of Burning Mouth Syndrome with Depressive and Anxiety Disorders in Middle-Aged and Older Adults: A Systematic Review

  • Authors: Dibello, V.; Ballini, A.; Lozupone, M.; Solfrizzi, V.; Panza, F.
  • Publication Year: 2023
  • Citations: 4

7. Oral Candidiasis and Novel Therapeutic Strategies: Antifungals, Phytotherapy, Probiotics, and Photodynamic Therapy

  • Authors: Contaldo, M.; Di Stasio, D.; Romano, A.; Serpico, R.; Lucchese, A.
  • Publication Year: 2023
  • Citations: 22

8. Oral Frailty Indicators to Target Major Adverse Health-Related Outcomes in Older Age: A Systematic Review

  • Authors: Dibello, V.; Lobbezoo, F.; Lozupone, M.; Manfredini, D.; Panza, F.
  • Publication Year: 2023
  • Citations: 50

9. Guided Bone Regeneration with Occlusive Titanium Barrier: A Case Report and Clinical Considerations

  • Authors: Milillo, L.; Petruzzi, M.
  • Publication Year: 2023
  • Citations: 1

 

Hyung-Youl Park | Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Assist. Prof. Dr. Hyung-Youl Park | Health Sciences | Best Researcher Award

Assistant Professor | Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea | South Korea 

Dr. Hyung-Youl Park is a Clinical Assistant Professor in the Department of Orthopedic Surgery at Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea. With a focus on spinal cord injuries, disc degeneration, adult spinal deformity, minimally invasive surgery, and osteoporosis, Dr. Park has established himself as a leading figure in both clinical and academic orthopedic surgery. His dedication to improving spinal health is evident in his extensive research, teaching, and clinical expertise.

Profile

Orcid

Strenghts for the Awards

  • Prolific Research Output:
    Dr. Hyung-Youl Park has published extensively, with 72 research articles, including 50 high-impact works in prestigious journals like the European Spine Journal, Diagnostics, World Neurosurgery, and Clinical Orthopaedics and Related Research. His contributions reflect a consistent focus on advancing orthopedic surgery, spinal diseases, and geriatric spinal care.
  • Diverse and Impactful Research Areas:
    His research spans critical topics such as:

    • Risk factors for mechanical complications in spinal surgeries.
    • Pathophysiology and treatment of Kummell’s Disease.
    • Effects of telemedicine on medical staff post-COVID-19.
    • Innovations in bone regeneration and biomaterials.
    • Geriatric spinal fusion and osteoporosis treatment strategies.
    • Surgical management of spinal metastases and deformities.

    These studies showcase clinical relevance and translational impact on improving patient outcomes, particularly in geriatric and oncology-related spinal care.

  • Collaboration and Leadership:
    Dr. Park has co-authored with notable experts like Young-Hoon Kim and Kee-Yong Ha, reflecting his active collaboration in multidisciplinary teams. His involvement in pivotal studies, such as surgical risk factors, spinal imaging, and regenerative medicine, indicates leadership in shaping clinical practices.
  • High-Impact Publications:
    Many of his works are published in journals indexed in Web of Science and Scopus, with notable DOI-linked contributions that enhance global accessibility. His study on telemedicine satisfaction post-pandemic (Telemedicine and e-Health, 2024) and innovative use of recombinant human BMP-2 (Bioengineering, 2023) demonstrate cutting-edge advancements.
  • Clinical Relevance and Recognition:
    Dr. Park’s research addresses real-world challenges, such as post-surgical complications, lumbar stenosis, and adjacent segment degeneration. His findings offer actionable insights for surgical decision-making and patient care optimization.

Education 🎓

Dr. Park holds an impressive academic background:

  • Ph.D. in Orthopedic Surgery (2022), The Catholic University Graduate School, Seoul, Korea.
    • Dissertation: “Are the Choice of Frame and Intraoperative Patient Positioning Associated with Radiologic and Clinical Outcomes in Long-Instrumented Lumbar Fusion for Adult Spinal Deformity?”
  • M.D. (2012), The Catholic University, College of Medicine, Seoul, Korea.

His postgraduate training includes internships, residency, and fellowships at renowned hospitals within the Catholic Medical Center in Korea.

Experience 🏥

Dr. Park’s professional journey spans over a decade of clinical expertise:

  • Clinical Assistant Professor (2020 – Present): Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea.
  • Clinical Fellow (2017–2020): Department of Orthopedic Surgery at Seoul and Eunpyeong St. Mary’s Hospitals.
  • Orthopedic Resident (2013–2017): Seoul St. Mary’s Hospital, Catholic Medical Center, Seoul, Korea.

He actively teaches medical students and residents and has played a pivotal role in weekly spine disorder reviews and conferences.

Research Interests 🔬

Dr. Park’s primary research interests include:

  • Spinal cord injury and disc degeneration.
  • Adult spinal deformity and minimally invasive spine surgery.
  • Osteoporosis and its effects on spinal health.

His research integrates basic science with clinical applications to improve patient outcomes in spine surgery.

Awards and Recognitions 🏆

Dr. Park’s work has earned numerous accolades:

  • Young Investigator Award, Korean Society of Spinal Surgery (2023).
  • Best Investigator Award, Department of Orthopedic Surgery, The Catholic University of Korea (2022).
  • Oral Presentation Awards for innovative research in osteoporosis and spinal tumors at multiple national and international congresses (2016–2021).
  • Nomination for Hibbs Award, Scoliosis Research Society (2017).

These honors reflect his commitment to advancing orthopedic surgery through groundbreaking research.

Publications 📚

Dr. Hyung-Youl Park has authored several impactful articles in high-ranking journals:

  1. “Risk factors for mechanical complications after fusion extension surgery for lumbar adjacent segment disease”
    • Authors: Kim, Young-Hoon; Ha, Kee-Yong; Ahn, Joonghyun; Park, Hyung-Youl; Chang, Dong-Gune; Lim, Jae-Hak; Kim, Sang-Il
    • Journal: European Spine Journal
    • DOI: 10.1007/S00586-023-07880-5
  2. “Understanding Kummell’s Disease: Definition, Diagnosis, Pathophysiology, and Treatment”
    • Authors: Young-Il Ko; Myung-Sup Ko; Chungwon Bang; Hyung-Youl Park; Sang-Il Kim; Young-Hoon Kim
    • Journal: Journal of Korean Society of Spine Surgery
    • DOI: 10.4184/jkss.2024.31.1.23
  3. “Sagittal Realignment Following Decompression for Lumbar Spinal Stenosis in Elderly Patients: A Comprehensive EOS Imaging Analysis”
  4. “Satisfaction Survey of Medical Staff for Telemedicine after the COVID-19 Pandemic”
    • Authors: Seung Eun Jung; Young-Mi Kwon; Soon-Yong Kwon; Young-Hoon Kim; Hyung-Youl Park
    • Journal: Telemedicine and e-Health
    • DOI: 10.1089/tmj.2024.0142
  5. “The Effects of Longer Use of Teriparatide on Clinical and Radiographic Outcomes after Spinal Fusion in Geriatric Patients”
    • Authors: Young-Hoon Kim; Kee-Yong Ha; Hyun W. Bae; Hyung-Youl Park; Young-Il Ko; Myung-Sup Ko; Sang-Il Kim
    • Journal: Medicina
    • DOI: 10.3390/medicina60060946
  1. “Effects of bone cement augmentation for uppermost instrumented vertebra on adjacent disc segment degeneration in lumbar fusions”
    • Authors: Lee, Jae-Won; Kim, Hun-Chul; Kim, Sang-Il; Min, Hyung-Ki; Ha, Kee-Yong; Park, Hyung-Youl; Cho, Chang-Hee; Sung, Hoon-Seok; Lim, Jae-Hak; Kim, Young-Hoon
    • Journal: World Neurosurgery
    • DOI: 10.1016/J.WNEU.2022.11.014
  2. “Junctional Failures at Both Ends After Long Fusion Arthrodesis Stopping at L5: Incidences and Risk Factors”
    • Authors: Kim, Y.-H.; Ha, K.-Y.; Park, H.-Y.; Ko, M.-S.; Ko, Y.-I.; Sin, K.-J.; Kim, S.-I
    • Journal: World Neurosurgery
    • DOI: 10.1016/j.wneu.2023.09.063
  3. “Predictive factors for conversion from conservative to surgical treatment in osteoporotic thoracolumbar compression fractures”
    • Authors: Sung, Hoon-Seok; Kim, Sang-Il; Park, Hyung-Youl; Ko, Myung-Sup; Lee, Jeong-Han; Kim, Young-Hoon
    • Journal: European Spine Journal
    • DOI: 10.1007/S00586-023-07864-5
  4. “Risk Factors for Conversion to Open Spinal Surgery after Percutaneous Epidural Neuroplasty”
    • Authors: Young-Hoon Kim; Sang-Il Kim; Jun-Seok Lee; Hyung-Youl Park
    • Journal: Journal of Korean Society of Spine Surgery
    • DOI: 10.4184/jkss.2023.30.1.18
  5. “When Should Spinal Surgery Be Considered for Spinal Metastasis from Non-Small Cell Lung Cancer?”
    • Authors: Hyung-Youl Park; Kee-Yong Ha; Sang-Il Kim; Yeon-Sil Kim; Yongwon Joh; Young-Hoon Kim
    • Journal: Journal of Clinical Medicine
    • DOI: 10.3390/jcm12144683

Conclusion

Dr. Hyung-Youl Park is a distinguished orthopedic surgeon, educator, and researcher dedicated to advancing spine health through innovative clinical practices and impactful research. His achievements reflect a blend of clinical expertise, academic excellence, and a passion for improving patient outcomes.